
403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Russia records its first case Chikungunya fever
(MENAFN) Russia reported its first case of Chikungunya fever on Friday, with the patient currently hospitalized in moderate condition, according to the country’s sanitary authority, Rospotrebnadzor.
The agency noted that it had previously warned about the risk of the disease being imported from abroad and had prepared specialists for such a situation. The infected individual had recently arrived in Moscow from Sri Lanka and initially sought treatment for suspected dengue fever, but tests confirmed a Chikungunya virus infection.
Rospotrebnadzor emphasized that there is no current risk of the disease spreading in Russia, as it is transmitted solely through mosquito bites, and local mosquito populations do not pose an epidemiological threat.
“All necessary anti-epidemic measures were promptly organized and implemented,” the agency said. It also highlighted border screening procedures for travelers coming from regions with significant infectious disease risks.
Chikungunya symptoms include fever, severe joint pain, muscle pain, nausea, fatigue, rash, and swollen joints
The agency noted that it had previously warned about the risk of the disease being imported from abroad and had prepared specialists for such a situation. The infected individual had recently arrived in Moscow from Sri Lanka and initially sought treatment for suspected dengue fever, but tests confirmed a Chikungunya virus infection.
Rospotrebnadzor emphasized that there is no current risk of the disease spreading in Russia, as it is transmitted solely through mosquito bites, and local mosquito populations do not pose an epidemiological threat.
“All necessary anti-epidemic measures were promptly organized and implemented,” the agency said. It also highlighted border screening procedures for travelers coming from regions with significant infectious disease risks.
Chikungunya symptoms include fever, severe joint pain, muscle pain, nausea, fatigue, rash, and swollen joints

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- BTCC Exchange Announces Triple Global Workforce Expansion At TOKEN2049 Singapore To Power Web3 Evolution
- Bydfi Joins Korea Blockchain Week 2025 (KBW2025): Deepening Web3 Engagement
- SPAYZ.Io White Paper Explores Opportunities, Challenges And Ambitions In Payments Industry
- Currency Relaunches Under New Leadership, Highlights 2025 Achievements
- Salvium Solves The Privacy Paradox: Salvium One Delivers Mica-Compliant Privacy That Exchanges Can List
- FLOKI Funds Clean Water Wells In Africa Through Partnership With WWFA
Comments
No comment